Literature DB >> 3211499

The effects of withdrawal of timolol in chronically treated glaucoma patients.

L P Schlecht1, R F Brubaker.   

Abstract

The dynamics of aqueous humor were studied before and after discontinuing timolol maleate in chronic users. Nineteen patients (mean length of treatment, 44 months) were studied by measuring their baseline intraocular pressure (IOP) and aqueous humor flow during treatment and 2 days to 6 weeks after discontinuing the drug. Flow did not increase significantly until 4 days after discontinuing timolol, and IOP did not increase significantly until 14 days later. Flow did not revert to its normal rate for 2 to 6 weeks. Intraocular pressure was 15% lower and the flow 24% lower during maintenance treatment than 1 month after discontinuing timolol. This comparison demonstrates the efficacy of chronic treatment. Recovery of aqueous flow is slow after stopping timolol. This finding suggests that lower or less frequent doses than are customarily used might be equally efficacious. If timolol is discontinued before filtration surgery, its effects will remain for 2 to 4 weeks.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3211499     DOI: 10.1016/s0161-6420(88)33026-5

Source DB:  PubMed          Journal:  Ophthalmology        ISSN: 0161-6420            Impact factor:   12.079


  9 in total

Review 1.  Efficacy and adverse effects of medications used in the treatment of glaucoma.

Authors:  C B Camras; C B Toris; R R Tamesis
Journal:  Drugs Aging       Date:  1999-11       Impact factor: 3.923

2.  Effects on IOP restoration and blood-aqueous barrier after long-term treatment with latanoprost in open angle glaucoma and ocular hypertension.

Authors:  C Lindén; E Nuija; A Alm
Journal:  Br J Ophthalmol       Date:  1997-05       Impact factor: 4.638

3.  Comparison of the intraocular pressure lowering effect of latanoprost and a fixed combination of timolol-pilocarpine eye drops in patients insufficiently controlled with beta adrenergic antagonists. French Latanoprost Study Group, and the Swedish Latanoprost Study Group.

Authors:  J P Nordmann; M Söderström; J F Rouland; F Malecaze
Journal:  Br J Ophthalmol       Date:  2000-02       Impact factor: 4.638

Review 4.  Diurnal variations in intraocular pressure.

Authors:  J T Wilensky
Journal:  Trans Am Ophthalmol Soc       Date:  1991

5.  Effect of latanoprost 0.005% and brimonidine tartrate 0.2% on pulsatile ocular blood flow in normal tension glaucoma.

Authors:  C Jui-Ling Liu; Y-C Ko; C-Y Cheng; J C Chou; W-M Hsu; J-H Liu
Journal:  Br J Ophthalmol       Date:  2002-11       Impact factor: 4.638

Review 6.  Ocular beta-blockers in glaucoma management. Clinical pharmacological aspects.

Authors:  A M Brooks; W E Gillies
Journal:  Drugs Aging       Date:  1992 May-Jun       Impact factor: 3.923

7.  Postural studies in pulsatile ocular blood flow: II. Chronic open angle glaucoma.

Authors:  D R Trew; S E Smith
Journal:  Br J Ophthalmol       Date:  1991-02       Impact factor: 4.638

8.  Clinical options for the reduction of elevated intraocular pressure.

Authors:  Laura Crawley; Sohaib M Zamir; Maria F Cordeiro; Li Guo
Journal:  Ophthalmol Eye Dis       Date:  2012-04-30

9.  Positional Intraocular Pressure of Vitrectomized and Normal Fellow Eyes.

Authors:  Jae Hyuck Lee; Jae Yeun Lee; Jeong Hun Bae; Joon Mo Kim
Journal:  Korean J Ophthalmol       Date:  2018-10
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.